The NHS is offering autumn Covid boosters to the most vulnerable in October. Many pharmacies also now sell the Covid jab ...

AZN's Daiichi Sankyo-partnered datopotamab deruxtecan fails to show overall survival benefits in a breast cancer study. Stock ...

Responding to rising mpox cases in Africa, the World Health Organization declared a public health emergency of international ...

"Vicebio secures $100m to advance RSV and hMPV vaccine combo to Phase I" was originally created and published by ...

Pfizer chief executive Ian Read is to go head-to-head with AstraZeneca's Pascal Soriot in two parliamentary hearings to argue for the future of the UK-based company. The two CEOs have been called ...

Earlier switch to atezolizumab after run-in with vemurafenib plus cobimetinib showed promise in improving OS rates in BRAF ...

Pfizer has announced a deal with AstraZeneca for exclusive over-the-counter (OTC) rights to market Nexium for approved indications in the United States, Europe and the rest of the world.

Biohaven's drug for a genetic disease that affects the nervous system met the main study goal, sending its shares up more ...

The FDA’s clearance could double Kisqali’s breast cancer market. Elsewhere, Novo is exploring new ways to deliver genetic ...

Axial Spondyloarthritis (axSpA) is a form of arthritis that mainly causes discomfort and inflammation in the spine and ...